AI assistant
AGENUS INC — Director's Dealing 2010
Jan 22, 2010
34023_dirs_2010-01-22_3ea9e1b9-3de0-4323-9109-51b789e989e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-01-19
Reporting Person: Sharp Shalini (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-01-19 | Common Stock | A | 136421 | $0.9 | Acquired | 300916 | Direct |
| 2010-01-20 | Common Stock | S | 63848 | $0.8534 | Disposed | 237068 | Direct |
Footnotes
F1: Represents settlement of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance.
F2: Represents only shares sold to cover minimum federal, state and local tax withholding requirements upon the vesting of the restricted shares granted in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.
F3: This amended filing is made to prpoerly reflect the shares as disposed. These shares were obtained from the vesting of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.